Lisinopril and Hydrochlorothiazide

Product NDC
50090-1109
11-digit product format
500901109
Labeler code
50090
Product ID
50090-1109_09962414-0b47-49f0-aa2b-face58269fdc
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
A-S Medication Solutions
Application
ANDA077912
Marketing category
ANDA
Marketing start
2006-10-04
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE; LISINOPRIL
Active strength
13 mg/1; mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
0J48LPH2THHYDROCHLOROTHIAZIDE58-93-5HYDROCHLOROTHIAZIDE
E7199S1YWRLISINOPRIL83915-83-7LISINOPRIL

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-1109-05009011090030 TABLET in 1 BOTTLE (50090-1109-0) 30 tablet2015-09-220000-00-00NoNoCurrent
50090-1109-15009011090190 TABLET in 1 BOTTLE (50090-1109-1) 90 tablet2014-11-280000-00-00NoNoCurrent

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USPA-S Medication Solutions2025-11-10HUMAN PRESCRIPTION DRUG LABEL37
LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS USPA-S Medication Solutions2024-01-01HUMAN PRESCRIPTION DRUG LABEL34